Semaglutide Injection: Incorrect Pen in Package
Brand(s)
Last updated
Summary
Product
Semaglutide Injection
Issue
Health products - Packaging
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Canada Inc. | Semaglutide Injection (labelled as 2mg/pen) | DIN 02567806 | Solution | 1.34 mg/ml | 7000544C |
Issue
The affected lot contains a 4 mg pen but is labelled as a 2 mg pen.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Retaillers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Recalling Firm
Dr. Reddy's Laboratories Canada Inc.
5580 Explorer Dr, Suite 204
Mississauga,ON L4W 4Y1
Market Authorization Holder
DR REDDY'S LABORATORIES LTD
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally
Medchal-Malkajgiri
Telangana
India 500090
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-82477
Get notified
Receive emails about new and updated recall and safety alerts.